Advisers Reject Strong ADHD Warnings
U.S. advisers on Wednesday called for new information about psychiatric and heart risks on the labels of attention deficit drugs but stopped short of recommending the strongest possible warning, saying they did not want to frighten patients or parents from effective treatment.